Dewey McLin

Direttore Tecnico/Scientifico/R&S presso LONGBOARD PHARMACEUTICALS, INC.

Health Technology

Consumer Services

Profilo

Dewey McLin is currently the Vice President & Head-Medical Affairs at Longboard Pharmaceuticals, Inc. Previously, he worked as the Senior Director-Medical Affairs at Greenwich Biosciences, Inc. and as the Vice President-Medical Affairs at Sesen Bio, Inc. for a brief period in 2021.
Dr. McLin completed his undergraduate degree at Indiana University and his doctorate at the University of California, Irvine.

Posizioni attive di Dewey McLin

Società	Posizione	Inizio
LONGBOARD PHARMACEUTICALS, INC.	Direttore Tecnico/Scientifico/R&S	-

Tutte le posizioni attive di Dewey McLin

Precedenti posizioni note di Dewey McLin

Società	Posizione	Fine
CARISMA THERAPEUTICS, INC.	Direttore Tecnico/Scientifico/R&S	01/09/2021
Greenwich Biosciences, Inc. Greenwich Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Greenwich Biosciences, Inc. develops and markets cannabinoid prescription medicines through online. The company is headquartered in Carlsbad, CA.	Direttore Tecnico/Scientifico/R&S	-

Vedi nel dettaglio l'esperienza di Dewey McLin

Formazione di Dewey McLin

Indiana University	Undergraduate Degree
University of California, Irvine	Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Dewey McLin

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
LONGBOARD PHARMACEUTICALS, INC.	Health Technology

Aziende private	2
Sesen Bio, Inc. Sesen Bio, Inc. Pharmaceuticals: MajorHealth Technology Sesen Bio, Inc. is a late-stage clinical company, which engages in the development of targeted fusion protein therapeutics. It offers Vicineum and Proxinium, which target tumor cell surface antigens that allow for rapid internalization into the targeted cancer cell and also have limited expression on normal cells. The company was founded by Reza Dana, K. Christopher Garcia, Gregory L. Verdine, Casey T. Weaver, and K. Dane Wittrup on February 25, 2008 and is headquartered in Cambridge, MA.	Health Technology
Greenwich Biosciences, Inc. Greenwich Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Greenwich Biosciences, Inc. develops and markets cannabinoid prescription medicines through online. The company is headquartered in Carlsbad, CA.	Health Technology